Halozyme finishes investigation of the production of recalled Hylenex

08/31/2010 | Los Angeles Times (tiered subscription model)

Halozyme Therapeutics has finished investigating how glass particles ended up in some vials of Hylenex, a fluid-absorption drug recalled by manufacturing partner Baxter International in May. The investigation found that the drug and the glass vial were incompatible. The companies are preparing to present their corrective action and relaunch strategy to the FDA.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR